Chapter/Section Purchase

1 Study Coverage
1.1 General Anxiety Disorder Therapeutics Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global General Anxiety Disorder Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global General Anxiety Disorder Therapeutics Market Size for the Year 2017-2028
1.2.2 Global General Anxiety Disorder Therapeutics Market Size for the Year 2017-2028
1.3 General Anxiety Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States General Anxiety Disorder Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of General Anxiety Disorder Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 General Anxiety Disorder Therapeutics Market Dynamics
1.4.1 General Anxiety Disorder Therapeutics Industry Trends
1.4.2 General Anxiety Disorder Therapeutics Market Drivers
1.4.3 General Anxiety Disorder Therapeutics Market Challenges
1.4.4 General Anxiety Disorder Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 General Anxiety Disorder Therapeutics by Type
2.1 General Anxiety Disorder Therapeutics Market Segment by Type
2.1.1 Itriglumide
2.1.2 Tedatioxetine
2.1.3 EDG-004
2.1.4 Others
2.2 Global General Anxiety Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global General Anxiety Disorder Therapeutics Market Size by Type (2017-2028)
2.4 United States General Anxiety Disorder Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States General Anxiety Disorder Therapeutics Market Size by Type (2017-2028)
3 General Anxiety Disorder Therapeutics by Application
3.1 General Anxiety Disorder Therapeutics Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global General Anxiety Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global General Anxiety Disorder Therapeutics Market Size by Application (2017-2028)
3.4 United States General Anxiety Disorder Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States General Anxiety Disorder Therapeutics Market Size by Application (2017-2028)
4 Global General Anxiety Disorder Therapeutics Competitor Landscape by Company
4.1 Global General Anxiety Disorder Therapeutics Market Size by Company
4.1.1 Top Global General Anxiety Disorder Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global General Anxiety Disorder Therapeutics Revenue by Player (2017-2022)
4.2 Global General Anxiety Disorder Therapeutics Concentration Ratio (CR)
4.2.1 General Anxiety Disorder Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of General Anxiety Disorder Therapeutics in 2021
4.2.3 Global General Anxiety Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global General Anxiety Disorder Therapeutics Headquarters, Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global General Anxiety Disorder Therapeutics Headquarters and Area Served
4.3.2 Global General Anxiety Disorder Therapeutics Companies Revenue in General Anxiety Disorder Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into General Anxiety Disorder Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States General Anxiety Disorder Therapeutics Market Size by Company
4.5.1 Top General Anxiety Disorder Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States General Anxiety Disorder Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global General Anxiety Disorder Therapeutics Market Size by Region
5.1 Global General Anxiety Disorder Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global General Anxiety Disorder Therapeutics Market Size by Region (2017-2028)
5.2.1 Global General Anxiety Disorder Therapeutics Market Size by Region: 2017-2022
5.2.2 Global General Anxiety Disorder Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific General Anxiety Disorder Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa General Anxiety Disorder Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa General Anxiety Disorder Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bionomics Limited
7.1.1 Bionomics Limited Company Details
7.1.2 Bionomics Limited Business Overview
7.1.3 Bionomics Limited General Anxiety Disorder Therapeutics Introduction
7.1.4 Bionomics Limited Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
7.1.5 Bionomics Limited Recent Development
7.2 Edgemont Pharmaceuticals, LLC
7.2.1 Edgemont Pharmaceuticals, LLC Company Details
7.2.2 Edgemont Pharmaceuticals, LLC Business Overview
7.2.3 Edgemont Pharmaceuticals, LLC General Anxiety Disorder Therapeutics Introduction
7.2.4 Edgemont Pharmaceuticals, LLC Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
7.2.5 Edgemont Pharmaceuticals, LLC Recent Development
7.3 H. Lundbeck A/S
7.3.1 H. Lundbeck A/S Company Details
7.3.2 H. Lundbeck A/S Business Overview
7.3.3 H. Lundbeck A/S General Anxiety Disorder Therapeutics Introduction
7.3.4 H. Lundbeck A/S Revenue in General Anxiety Disorder Therapeutics Business (2017-2022)
7.3.5 H. Lundbeck A/S Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer